» Articles » PMID: 1991444

Relationship of Limited Joint Mobility to Abnormal Foot Pressures and Diabetic Foot Ulceration

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1991 Jan 1
PMID 1991444
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the role of limited joint mobility (LJM) in causing abnormal foot pressures and foot ulceration.

Research Design And Methods: The subjects were recruited from a general diabetes clinic where patients were screened for neuropathy, retinopathy, and elevated plantar foot pressure. Sixty-four patients in five groups were matched by age and sex in the following groups: group 1, patients with LJM and neuropathy; group 2, nonneuropathic diabetic patients with LJM; group 3, patients with neuropathy and no LJM; group 4, diabetic control subjects; and group 5, nondiabetic control subjects. Joint mobility was assessed in the foot at subtalar and metatarsophalangeal joints; plantar foot pressures were assessed by optical pedobarography and neuropathic status by a Biothesiometer and electrophysiology.

Results: Joint mobility was reduced at both sites in groups 1 and 2 compared with groups 3, 4, and 5 (P less than 0.001). Plantar foot pressures were significantly higher in groups 1 and 2 compared with groups 3, 4, and 5 (P less than 0.001). No differences in plantar foot pressures were observed between groups 1 and 2. There were strong correlations between plantar foot pressures and joint mobility in the foot (r = -0.7, P less than 0.001). Previous foot ulceration was present in 65% of patients in group 1, none in group 2, and 5% in group 3.

Conclusions: 1) LJM may be a major factor in causing abnormally high plantar foot pressures, 2) abnormal plantar foot pressures alone do not lead to foot ulceration, and 3) LJM contributes to foot ulceration in the susceptible neuropathic foot.

Citing Articles

Effect of three-week exercise program on muscle strength and joint mobility in patients with diabetic polyneuropathy: Randomized controlled trial.

Novakovic-Bursac S, Talic G, Tomic N, Skrbic R, Soldatovic I World J Diabetes. 2024; 15(12):2311-2321.

PMID: 39676803 PMC: 11580598. DOI: 10.4239/wjd.v15.i12.2311.


Association between sarcopenia and the foot-ankle function in type 2 diabetic foot ulcer.

An S, Kuang W, Hu Y, Li X, Dong B, Li C Diabetol Metab Syndr. 2024; 16(1):270.

PMID: 39533341 PMC: 11559071. DOI: 10.1186/s13098-024-01507-5.


Effectiveness of a web-based foot-ankle exercise program for treating ulcer risk factors in diabetic neuropathy in a randomized controlled trial.

Ferreira J, Cruvinel-Junior R, da Silva E, Verissimo J, Monteiro R, Duarte M Sci Rep. 2024; 14(1):27291.

PMID: 39516524 PMC: 11549312. DOI: 10.1038/s41598-024-78188-7.


Impact of diabetic peripheral neuropathy on gait abnormalities in patients with type 2 diabetes mellitus.

Khalil S, Deeb H, Ajang M, Osman N, Amin N Diabetol Int. 2024; 15(1):58-66.

PMID: 38264222 PMC: 10800313. DOI: 10.1007/s13340-023-00652-y.


Assessment of selected muscle damage markers and zonulin concentration after maximum-intensity exercise in men with type 1 diabetes treated with a personal insulin pump.

Matejko B, Tota L, Morawska-Tota M, Palka T, Malecki M, Klupa T Acta Diabetol. 2023; 60(12):1675-1683.

PMID: 37481476 PMC: 10587266. DOI: 10.1007/s00592-023-02157-1.